Pompano Beach, FL, Feb. 08, 2018 (GLOBE NEWSWIRE) — (GLOBE NEWSWIRE) – BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or a “Company”), a tellurian life sciences corporation, providing innovative technologies with a thoroughness in Pharmaceuticals and Regenerative Medicine, announced today, a employing of Larry Jones, as Chief Revenue Officer. Mr. Jones comes to BioStem Tech from CJ Analytics, an analytics-based CRM company, where he served as Chief Business Strategist, obliged for running that company’s vital clients in generating incremental income by softened Customer Relationship Management, sales expansion and marketing. Prior to that, he served as Chief Sales Officer during Skypatrol LLC, overseeing Skypatrol’s sales and business development, patron use and support, and production organizations. Before that (in 2003), Mr. Jones founded Enfotrace LLC (now Spireon LLC), a GPS record company, that he successfully sole to Bertram Capital, 8 years later. “Larry’s knowledge in generating fast flourishing income streams, and also in privately building a association that captivated a private equity buy out, will be an useful further to BioStem’s government team,” pronounced Henry Van Vurst, BioStem’s CEO. “We’re really vehement to have someone with that turn of knowledge focused only on building a several income streams, and we are looking brazen to fast expansion underneath Mr. Jones’ direction.”
About BioStem Technologies, Inc. (OTC PINK: BSEM): BioStem Technologies, Inc. is a tellurian life sciences corporation, providing innovative technologies with a thoroughness in Pharmaceuticals and Regenerative Medicine. The Company’s goal is to discover, rise and furnish a many effective Pharmaceutical and Regenerative Medicine products in a world. The Company is comprised of a different organisation of scientists, physicians, and entrepreneurs who combine to emanate innovative products. These technologies urge a Quality of Life for a patients and, as a result, expostulate shareholder value.
Forward-Looking Statements: Except for statements of chronological fact, a matters discussed in this press recover are brazen looking and done pursuant to a Safe Harbor supplies of a Private Securities Litigation Reform Act of 1995. “Forward looking statements” report destiny expectations, plans, results, or strategies and are generally preceded by difference such as “future,” “plan” or “planned,” “expects,” believe” or “projected.” These forward-looking statements simulate countless assumptions and engage a accumulation of risks and uncertainties, many of that are over a company’s control that might means tangible formula to differ materially from settled expectations. These risk factors include, among others, singular handling history, problem in developing, exploiting and safeguarding exclusive technologies, heated foe and additional risks factors as discussed in reports filed by a association with OTC Markets.
BioStem Technologies, Inc. Phone: 954-380-8342 Website: http://www.biostemtech.com Email: info@biostemtech.com Twitter: @Biostemtech Facebook: BioStem Technologies Investor Relations: Andrew Van Vurst info@biostemtech.com (954) 380-8342
